Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mohammad Alsaggar"'
Autor:
Nid’a Alshraiedeh, Farah Atawneh, Rasha Bani-Salameh, Rawan Alsharedeh, Yara Al Tall, Mohammad Alsaggar
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 2796-2804 (2022)
Background Notable emergence of multidrug-resistant bacteria has become increasingly problematic worldwide. Most patients with cystic fibrosis (CF) suffer from chronic persistent infections with frequent occurrence of acute exacerbations. Routine scr
Externí odkaz:
https://doaj.org/article/2ceb33b2809848628771f04d89203268
Autor:
Mohammad Alsaggar, Mohammad Al-Hazabreh, Yara Al Tall, Alaa Al-Tarawneh, Ruba S. Darweesh, Majed Masadeh
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 11, Pp 1652-1658 (2022)
Objective: The growing microbial resistance to antibiotics is a global public concern, which creates serious needs for newer antimicrobial agents. Antimicrobial peptides (AMPs) are increasingly exploited in drug development as therapeutic candidates.
Externí odkaz:
https://doaj.org/article/fe3de3f6d3ff4db6963b1c18a513f231
Autor:
Mohammad Alsaggar, Shifa Bdour, Qutaibah Ababneh, Tamam El-Elimat, Nidal Qinna, Karem H. Alzoubi
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract Background Obesity is a multifactorial chronic disease that comprises several pathological events, such as adipose hypertrophy, fatty liver and insulin resistance. Inflammation is a key contributer to development of these events, and therefo
Externí odkaz:
https://doaj.org/article/819379f32b0d4387bb21962624ea99c6
Table S3. List of miRNAs downregulated (fold difference {greater than or equal to} 1.5 in MIA PaCa-2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2e18b47d9083902f72e7cb2bcfcc83
https://doi.org/10.1158/1541-7786.22514917
https://doi.org/10.1158/1541-7786.22514917
1. Supplemental Materials and Methods & Supplemental Figures (Fig. S1-S13) 2. Supplemental Tables (Table S1-S8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70feba56c442a7a5bbcfe5a063b7254d
https://doi.org/10.1158/1541-7786.22514923
https://doi.org/10.1158/1541-7786.22514923
Autor:
Tamam El-Elimat, Bayan K. Al-Tal, Nour A. Al-Sawalha, Mohammad Alsaggar, Shreen D. Nusair, Reema Al‐Qiam, Ahmed H. Al Sharie, Feras El Hajji, Lama Hamadneh
Publikováno v:
Food Bioscience. 52:102488
Publikováno v:
Current pharmaceutical design. 28(26)
Background: Managing bacterial infections caused by multidrug-resistant (MDR) and biofilmforming bacteria is a global health concern. Therefore, enormous efforts were directed toward finding potential alternative antimicrobial agents, such as antimic
Autor:
Ahmad Abualhaijaa, Mohammad Alsaggar, Majed M Masadeh, Yara Al Tall, Mohammed T Qaoud, Karem H. Alzoubi
Publikováno v:
Current Pharmaceutical Biotechnology. 20:745-754
Background:The over use of current antibiotics and low discovery rate of the new ones are leading to rapid development of multidrug-resistant pathogens worldwide. Antimicrobial peptides have shown promising results against multidrug-resistant bacteri
Autor:
Ahmad Abualhaijaa, Mohammad Alsaggar, Karem H. Alzoubi, Yara Al Tall, Ammar Almaaytah, Majed M Masadeh
Publikováno v:
Infection and Drug Resistance. 12:1035-1045
Background and purpose: The world is heading to a post-antibiotic era where the treatment of bacterial infections will not be possible even with well-known last-line antibiotics. Unfortunately, the emergence of multidrug resistant bacterial strains i
Autor:
Shifa Bdour, Nidal A. Qinna, Karem H. Alzoubi, Qutaibah Ababneh, Mohammad Alsaggar, Tamam El-Elimat
Publikováno v:
BMC Pharmacology & Toxicology
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-8 (2020)
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-8 (2020)
Background Obesity is a multifactorial chronic disease that comprises several pathological events, such as adipose hypertrophy, fatty liver and insulin resistance. Inflammation is a key contributer to development of these events, and therefore, targe